We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$1.83B
AUM Growth
+$115M
Cap. Flow
-$45M
Cap. Flow %
-2.46%
Top 10 Hldgs %
9%
Holding
431
New
12
Increased
73
Reduced
82
Closed
22

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$5.27M
2
ABEV icon
Ambev
ABEV
+$4.75M
3
EPD icon
Enterprise Products Partners
EPD
+$3.74M
4
GLPI icon
Gaming and Leisure Properties
GLPI
+$3.21M
5
GPN icon
Global Payments
GPN
+$2.56M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$6.74M
2
UNP icon
Union Pacific
UNP
+$5.86M
3
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
+$4.99M
4
DRI icon
Darden Restaurants
DRI
+$4.72M
5
PENN icon
PENN Entertainment
PENN
+$3.17M

Sector Composition

Rank Sector Weight
1 Industrials 23.01%
2 Consumer Discretionary 13.51%
3 Financials 11.36%
4 Healthcare 11.27%
5 Technology 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
151
UnitedHealth
UNH
$373B
$4.37M 0.24%
58,000
– –
TRP icon
152
TC Energy
TRP
$65.7B
$4.36M 0.24%
95,400
– –
IHS
153
DELISTED
IHS INC CL-A COM STK
IHS
$4.34M 0.24%
36,300
– –
BCE icon
154
BCE
BCE
$21B
$4.33M 0.24%
100,000
+12,000
+14% +$522K
CLB icon
155
Core Laboratories
CLB
$541M
$4.22M 0.23%
22,100
– –
VFC icon
156
VF Corp
VFC
$5.87B
$4.19M 0.23%
71,366
– –
CLH icon
157
Clean Harbors
CLH
$16.5B
$4.08M 0.22%
68,100
– –
AMGN icon
158
Amgen
AMGN
$224B
$4.08M 0.22%
35,700
– –
ORCL icon
159
Oracle
ORCL
$431B
$4.04M 0.22%
105,500
-16,000
-13% -$550K
TROW icon
160
T. Rowe Price
TROW
$24.4B
$4.02M 0.22%
48,000
-16,000
-25% -$1.25M
EPD icon
161
Enterprise Products Partners
EPD
$82B
$3.98M 0.22%
+120,000
New +$3.74M
DD
162
DELISTED
Du Pont De Nemours E I
DD
$3.96M 0.22%
64,233
– –
BMO icon
163
Bank of Montreal
BMO
$128B
$3.93M 0.21%
59,000
-12,000
-17% -$817K
JJSF icon
164
J&J Snack Foods
JJSF
$1.68B
$3.93M 0.21%
44,400
– –
ADT
165
DELISTED
ADT Corp
ADT
$3.93M 0.21%
97,100
+16,000
+20% +$658K
PRE
166
DELISTED
PARTNERRE LTD
PRE
$3.86M 0.21%
36,600
+2,000
+6% +$197K
TGT icon
167
Target
TGT
$69.2B
$3.69M 0.2%
58,400
– –
APD icon
168
Air Products & Chemicals
APD
$68.1B
$3.69M 0.2%
35,673
– –
TEVA icon
169
Teva Pharmaceuticals
TEVA
$41.1B
$3.66M 0.2%
91,237
-12,500
-12% -$492K
EXPD icon
170
Expeditors International
EXPD
$23.3B
$3.65M 0.2%
82,500
– –
ARG
171
DELISTED
Airgas Inc
ARG
$3.65M 0.2%
32,600
-3,000
-8% -$327K
INGR icon
172
Ingredion
INGR
$6.55B
$3.63M 0.2%
53,100
– –
BMY icon
173
Bristol-Myers Squibb
BMY
$133B
$3.58M 0.2%
67,400
– –
RTN
174
DELISTED
Raytheon Company
RTN
$3.53M 0.19%
38,900
– –
BDX icon
175
Becton Dickinson
BDX
$48.5B
$3.45M 0.19%
31,980
+3,075
+11% +$319K
5 6
7
8 9

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

EULAV Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, EULAV Asset Management held 431 positions worth $1.83B, up 6.7% from $1.72B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

EULAV Asset Management's Q4 2013 filing shows 12 new, 73 increased, 82 reduced and 22 closed positions. Its largest new stake was Allergan plc: 33,700 shares worth $5.66M. The largest sale was Nike, an estimated $6.74M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • EULAV Asset Management's largest Q4 2013 buy was Allergan plc: 33,700 shares worth $5.66M.
  • EULAV Asset Management added most to McKesson in Q4 2013, an estimated $1.54M increase.
  • EULAV Asset Management's biggest Q4 2013 reduction was Nike, cutting an estimated $6.74M.
  • EULAV Asset Management fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $4.99M.
  • EULAV Asset Management's ten largest holdings make up 9% of its $1.83B portfolio in Q4 2013.
  • EULAV Asset Management opened 12 new positions and closed 22 in Q4 2013.
  • EULAV Asset Management's portfolio value rose 6.7% quarter-over-quarter to $1.83B.

Based on EULAV Asset Management's 13F filing for Q4 2013, filed 18 Feb 2014.